Search Results - "Lanzolla, G."

Graves’ disease and Graves’ orbitopathy following COVID-19 by Lanzolla, G., Marcocci, C., Marinò, M.

Get full text

Sirolimus as a second-line treatment for Graves’ orbitopathy by Lanzolla, G., Maglionico, M. N., Comi, S., Menconi, F., Piaggi, P., Posarelli, C., Figus, M., Marcocci, C., Marinò, M.

“…Objectives A beneficial effect of sirolimus in Graves’ orbitopathy (GO) was reported, suggesting a possible use in clinical practice. We conducted an…”
Get full text

Orbital diseases mimicking graves’ orbitopathy: a long-standing challenge in differential diagnosis by Marinò, M., Ionni, I., Lanzolla, G., Sframeli, A., Latrofa, F., Rocchi, R., Marcocci, C.

“…Graves’ orbitopathy (GO) is the most common cause of orbital tissue inflammation, accounting for ~ 60% of all orbital inflammatory conditions in the population…”
Get full text

Occurrence of Graves’ hyperthyroidism and Graves’ orbitopathy after fine-needle aspiration biopsy of thyroid nodules by Lanzolla, G., Marcocci, C., Marinò, M.

Get full text

IgG4 serum levels in Graves’ orbitopathy by Comi, S., Lanzolla, G., Cosentino, G., Maglionico, M. N., Posarelli, C., Menconi, F., Santini, F., Elisei, R., Marinò, M.

“…Objective IgG4-related disease (IgG4-RD) can involve many organs, including thyroid and orbital tissues. A link between IgG4, Graves’ disease (GD) and Graves’…”
Get full text

Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy by Nicolì, F., Lanzolla, G., Mantuano, M., Ionni, I., Mazzi, B., Leo, M., Sframeli, A., Posarelli, C., Maglionico, M. N., Figus, M., Nardi, M., Marcocci, C., Marinò, M.

“…Background Graves’ orbitopathy (GO) is the most common extrathyroidal manifestation of Graves’ disease (GD). Several studies support the involvement of TSH…”
Get full text

Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study by Rotondo Dottore, G., Torregrossa, L., Lanzolla, G., Mariotti, S., Menconi, F., Piaggi, P., Cristofani Mencacci, L., Posarelli, C., Maglionico, M. N., Dallan, I., Figus, M., Nardi, M., Marcocci, C., Basolo, F., Marinò, M.

“…Objective The extent to which mononuclear cells and TSH-receptor autoantibodies (TRAb) contribute to Graves’ orbitopathy (GO) is not completely defined. Here…”
Get full text

Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study by Lanzolla, G., Sabini, E., Profilo, M. A., Mazzi, B., Sframeli, A., Rocchi, R., Menconi, F., Leo, M., Nardi, M., Vitti, P., Marcocci, C., Marinò, M.

“…Background It has been suggested that high cholesterol represents a risk factor for Graves’ orbitopathy (GO). In a recent cross-sectional study, a correlation…”
Get full text

Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy by Marinò, M., Rotondo Dottore, G., Ionni, I., Lanzolla, G., Sabini, E., Ricci, D., Sframeli, A., Mazzi, B., Menconi, F., Latrofa, F., Vitti, P., Marcocci, C., Chiovato, L.

“…Background A role of the insulin-like growth factor-1 receptor (IGF-1R) in the pathogenesis of Graves’ orbitopathy (GO) has been proposed, but the existence…”
Get full text

Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy by Lanzolla, G., Puccinelli, L., Giudetti, M., Comi, S., Menconi, F., Maglionico, M. N., Posarelli, C., Figus, M., Marcocci, C., Marinò, M.

“…Objective A relationship between thyroid and non-organ-specific autoimmunity could be relevant for Graves’ orbitopathy (GO), which affects connective tissue…”
Get full text

Absence of a relationship between vitamin D and Graves’ orbitopathy by Lanzolla, G., Di Matteo, L., Comi, S., Cosentino, G., Menconi, F., Maglionico, M. N., Posarelli, C., Figus, M., Marinò, M.

Get full text

Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study by Lanzolla, G., Ricci, D., Nicolì, F., Sabini, E., Sframeli, A., Brancatella, A., Mantuano, M., Dottore, G. R., Bucci, I., Figus, M., Nardi, M., Latrofa, F., Marcocci, C., Marinò, M.

“…Background The insulin-like growth factor-1 receptor (IGF-1R) is a key element in the pathogenesis of Graves’ Orbitopathy (GO), but the role of IGF-1R…”
Get full text

The half-truth of first-mover advantage by Suarez, Fernando, Lanzolla, Gianvito

“…Many executives take for granted that the first company in a new product category gets an unbeatable head start and reaps long-lasting benefits. But that…”
Get more information

Adoption of e-Processes by Service Firms: An Empirical Study of Antecedents by Tsikriktsis, Nikos, Lanzolla, Gianvito, Frohlich, Mark

“…This paper investigates empirically antecedents of the adoption of web‐based processes (e‐processes) by service providers. We examine whether rational…”
Get full text

Graves' disease and Graves' orbitopathy following COVID-19 by Lanzolla, G, Marcocci, C, Marinò, M

Get full text

Occurrence of Graves' hyperthyroidism and Graves' orbitopathy after fine-needle aspiration biopsy of thyroid nodules by Lanzolla, G, Marcocci, C, Marinò, M

Get full text